Niki BioSolutions (NIKI) Gross Margin (2025)
Niki BioSolutions (NIKI) posted Gross Margin of 70.87% for FY2025.
Powered by 
Analysis
Niki BioSolutions (NIKI) Gross Margin (2025) Analysis & Trends
- Annual Gross Margin shows a three-year change of +64.69 percentage points (FY2022 to FY2025).
- Business Quant data shows NIKI's Gross Margin at 2.45% in FY2023 (-3.73 pp) and 6.18% in FY2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | Niki BioSolutions | 2.58 Mn | 2.58 Mn | - | - |
API Access
Niki BioSolutions Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=NIKI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "NIKI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=NIKI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();